Schedule 13D ownership disclosure

Auspex Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 05211J102

Event date: 2015-04-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,309,722
Percent of class
4.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001319244-15-000027
Form type
SC 13D
Filer
Auspex Pharmaceuticals, Inc.
CIK
CIK 1454189
Filed
Apr 10, 2015
Reporting period
Apr 02, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub